Truist Financial’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17K | Hold |
10,500
| – | – | ﹤0.01% | 2565 |
|
|
2025
Q1 | $10.2K | Hold |
10,500
| – | – | ﹤0.01% | 2511 |
|
|
2024
Q4 | $17.9K | Hold |
10,500
| – | – | ﹤0.01% | 2478 |
|
|
2024
Q3 | $29.8K | Buy |
+10,500
| New | +$29.8K | ﹤0.01% | 2451 |
|
|
2021
Q4 | – | Sell |
-1,944
| Closed | -$88K | – | 2752 |
|
|
2021
Q3 | $88K | Hold |
1,944
| – | – | ﹤0.01% | 2607 |
|
|
2021
Q2 | $107K | Hold |
1,944
| – | – | ﹤0.01% | 2616 |
|
|
2021
Q1 | $119K | Hold |
1,944
| – | – | ﹤0.01% | 2541 |
|
|
2020
Q4 | $139K | Hold |
1,944
| – | – | ﹤0.01% | 2410 |
|
|
2020
Q3 | $142K | Buy |
1,944
+388
| +25% | +$28.3K | ﹤0.01% | 2290 |
|
|
2020
Q2 | $135K | Hold |
1,556
| – | – | ﹤0.01% | 2236 |
|
|
2020
Q1 | $85K | Hold |
1,556
| – | – | ﹤0.01% | 2232 |
|
|
2019
Q4 | $128K | Hold |
1,556
| – | – | ﹤0.01% | 2370 |
|
|
2019
Q3 | $155K | Hold |
1,556
| – | – | ﹤0.01% | 764 |
|
|
2019
Q2 | $175K | Hold |
1,556
| – | – | ﹤0.01% | 760 |
|
|
2019
Q1 | $113K | Buy |
1,556
+556
| +56% | +$40.4K | ﹤0.01% | 757 |
|
|
2018
Q4 | $94K | Hold |
1,000
| – | – | ﹤0.01% | 748 |
|
|
2018
Q3 | $144K | Hold |
1,000
| – | – | ﹤0.01% | 762 |
|
|
2018
Q2 | $161K | Hold |
1,000
| – | – | ﹤0.01% | 743 |
|
|
2018
Q1 | $162K | Hold |
1,000
| – | – | ﹤0.01% | 741 |
|
|
2017
Q4 | $167K | Hold |
1,000
| – | – | ﹤0.01% | 773 |
|
|
2017
Q3 | $215K | Hold |
1,000
| – | – | ﹤0.01% | 744 |
|
|
2017
Q2 | $168K | Buy |
1,000
+556
| +125% | +$93.4K | ﹤0.01% | 759 |
|
|
2017
Q1 | $47K | Buy |
444
+222
| +100% | +$23.5K | ﹤0.01% | 814 |
|
|
2016
Q4 | $46K | Buy |
+222
| New | +$46K | ﹤0.01% | 823 |
|